Search
09/03/2025
Transcriptional Expression of SLC2A3 and SDHA Predicts the Risk of Local Tumor Recurrence in Patients with Head and Neck Squamous Cell Carcinomas Treated Primarily with Radiotherapy or Chemoradiotherapy
Camacho, M, Bagué, S, Valero, C, Holgadó, A, Lopez-Vilaro, L, Terra, X, Avilés-Jurado, FX, León, X. Transcriptional Expression of SLC2A3 and SDHA Predicts the Risk of Local Tumor Recurrence in Patients with Head and Neck Squamous Cell Carcinomas Treated Primarily with Radiotherapy or Chemoradiotherapy. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(6)DOI:10.3390/ijms26062451. PMID:40141095. IF:4.900(Q1/3D).
07/03/2025
No significant differences in postoperative clinical outcomes evolution after fresh osteochondral allograft transplantation of the knee between patients with pathological and non-pathological scores regarding anxiety, depression, kinesiophobia and catastrophizing factors
Gelber, PE, Ramírez-Bermejo, E, Castellà-Pujol, A, Gonzalez-Osuna, A, Fariñas, O. No significant differences in postoperative clinical outcomes evolution after fresh osteochondral allograft transplantation of the knee between patients with pathological and non-pathological scores regarding anxiety, depression, kinesiophobia and catastrophizing factors. Journal Of Experimental Orthopaedics. 2025; 12(1)DOI:10.1002/jeo2.70210. PMID:40059956. IF:(Q/D).
07/03/2025
Sex-dependent increases in oxytocin levels in response to intravenous kisspeptin in humans
Galbiati, F, Plessow, F, Plummer, L, Campbell, MB, Nazarloo, S, Carter, CS, Carroll, RS, Kim, HK, Pereira, SA, Paulis, D, Davis, JM, Miller, KK, Kaiser, UB, Seminara, SB, Aulinas, A, Lawson, EA. Sex-dependent increases in oxytocin levels in response to intravenous kisspeptin in humans. EUROPEAN JOURNAL OF ENDOCRINOLOGY. 2025; 192(3)DOI:10.1093/ejendo/lvaf001. PMID:39965102. IF:5.200(Q1/2D).
05/03/2025
Heterogeneity of cognitive progression and clinical predictors in Parkinson's disease-subjective cognitive decline
Rodríguez-Antigüedad, J, Martinez-Horta, S, Puig-Davi, A, Horta-Barba, A, Pagonabarraga, J, Fonticoba, TD, Jesús, S, Cosgaya, M, Caldentey, JG, avila-Rivera, MA, Caballol, N, Legarda, I, Vara, JH, Cabo, I, Manzanares, LL, Aramburu, IG, Mayordomo, VG, Ardura, JG, Garcia-Soto, JD, Borrue, C, Vila, BS, Sauco, MA, Vela, L, Escalante, S, Cubo, E, Mendoza, Z, Parees, I, Alonso, PS, Losada, MGA, Ariztegui, NL, Gaston, I, Martinez, JR, Buongiorno, MT, Ordas, C, Valero, C, Puente, V, Kurtis, M, Estrada, MB, Martínez-Martín, P, Mir, P, Santos-García, D, Kulisevsky, J. Heterogeneity of cognitive progression and clinical predictors in Parkinson's disease-subjective cognitive decline. JOURNAL OF NEUROLOGY. 2025; 272(3)DOI:10.1007/s00415-024-12808-0. PMID:40042541. IF:4.600(Q1/2D).
05/03/2025
Optimizing CAR-T treatment: A T2EVOLVE guide to raw and starting material selection
Navarro, S, Moukheiber, C, Sancho, SI, Guillén, MR, de Cerio, ALD, Sanges, C, Tanaka, T, Arnould, S, Briones, J, Dolstra, H, Hudecek, M, Choudhary, R, Schapitz, I, Juan, ME, Worel, N, Ammar, D, Luu, M, Mueller, M, Schroeder, B, Negre, H, Franz, P. Optimizing CAR-T treatment: A T2EVOLVE guide to raw and starting material selection. MOLECULAR THERAPY. 2025; 33(3)DOI:10.1016/j.ymthe.2024.11.017. PMID:39533710. IF:12.000(Q1/1D).
04/03/2025
Sex-related differences in genetically determined Alzheimer's disease
Soriano, LD, Wagemann, O, Bejanin, A, Levin, J, Fortea, J. Sex-related differences in genetically determined Alzheimer's disease. Frontiers in Aging Neuroscience. 2025; 17DOI:10.3389/fnagi.2025.1522434. PMID:40103931. IF:4.500(Q1/2D).